Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RENA MONTGOMERY

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1871728436
CMS profile
11225523
Location
SOUTHAVEN, MS

General Payments · PY2021–2024

$2,769.41

  • Reported across 112 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$278.37

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $224.97 13
Education $53.40 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
MILLICENT US INC $69.76 2
MAYNE PHARMA COMMERCIAL LLC $60.36 4
Exeltis, USA Inc. $44.69 2
SHIELD THERAPEUTICS INC $32.26 2
Lilly USA, LLC $19.95 1
Novo Nordisk AS $17.54 1
PFIZER INC. $17.40 1
Astellas Pharma US Inc $16.41 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,084.53 46
PY2022 $727.09 30
PY2023 $679.42 22
PY2024 $278.37 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $16.41 08/12/2024 Food and Beverage Undisputed 01/23/2026 1139522564 CMS
Exeltis, USA Inc. $21.54 08/12/2024 Food and Beverage Undisputed 01/23/2026 1150016715 CMS
Exeltis, USA Inc. $23.15 10/31/2024 Food and Beverage Undisputed 01/23/2026 1150016717 CMS
Lilly USA, LLC $19.95 08/21/2024 Food and Beverage Undisputed 01/23/2026 1135929126 CMS
MAYNE PHARMA COMMERCIAL LLC $15.56 01/29/2024 Food and Beverage Undisputed 01/23/2026 1154686649 CMS
MAYNE PHARMA COMMERCIAL LLC $18.47 04/10/2024 Food and Beverage Undisputed 01/23/2026 1154686645 CMS
MAYNE PHARMA COMMERCIAL LLC $3.89 04/24/2024 Food and Beverage Undisputed 01/23/2026 1154686647 CMS
MAYNE PHARMA COMMERCIAL LLC $22.44 08/15/2024 Food and Beverage Undisputed 01/23/2026 1154686651 CMS
MILLICENT US INC $16.36 10/28/2024 Food and Beverage Undisputed 01/23/2026 1150916034 CMS
MILLICENT US INC $53.40 10/28/2024 Education Undisputed 01/23/2026 1150916036 CMS
Novo Nordisk Inc $17.54 07/10/2024 Food and Beverage Undisputed 01/23/2026 1100328842 CMS
PFIZER INC. $17.40 07/15/2024 Food and Beverage Undisputed 01/23/2026 1131795808 CMS
SHIELD THERAPEUTICS INC $17.49 05/17/2024 Food and Beverage Undisputed 01/23/2026 1150131421 CMS
SHIELD THERAPEUTICS INC $14.77 08/19/2024 Food and Beverage Undisputed 01/23/2026 1150142670 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.